Dermatology Drugs Investment Global Outlook 2020

Dermatology Drugs Investment Global Outlook 2020

The global dermatology drugs market is expected to grow from $40.7 billion in 2019 to $44.0 billion in 2020 at a CAGR of 8.22%, despite the economic slowdown across countries owing to the pandemic outbreak. The market is then expected to recover and grow at a CAGR of 12.62% from 2020 to reach $62.8 billion in 2023.

Dermatology Drugs Investment Global Outlook 2020 provides strategists, marketers and senior management with the critical information they need to assess the global dermatology drugs sector.

Reasons to Purchase

  • Fully updated for 2020 including the impact of the Covid 19/ Novel Coronavirus.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and key trends
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.
Description

Dermatology Drugs Investment Global Outlook 2020 from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the dermatology drugs market revenues, covering both the historic growth of the market and forecasting the future.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

The trends and strategies section highlights the likely future developments in the dermatology drugs market and suggests approaches.

Scope

Markets Covered: Psoriasis; Dermatitis; Acne; Other Drugs for Dermatology Diseases

Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East, Africa

Countries: Australia, China, Hong Kong, India, Indonesia, Japan, South Korea, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam, Canada, USA, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, the UK, Czech Republic, Poland, Romania, Russia, Israel, Saudi Arabia, Turkey, UAE, Egypt, Nigeria, South Africa

Time series: Five years historic and forecast

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


1. Dermatology Drugs Market Characteristics
2. Dermatology Drugs Market Trends And Strategies
2.1. Immune Modulators To Treat Eczema
2.2. Genome Testing To Speed Clinical Trials Of Drugs
2.3. Increase In Mergers And Acquisitions Activity
2.4. Early Rx-To-Otc Switch
2.5. 3d Printing Technology
2.6. Robotics And Automation In Manufacturing Drugs
3. Dermatology Drugs Market Historic Growth
3.1. Drivers Of The Market
3.2. Restraints On The Market
4. Dermatology Drugs Market Forecast Growth
4.1. Drivers Of The Market
4.2. Restraints On The Market
5. Dermatology Drugs Market Segmentation
5.1. Global Dermatology Drugs Market, Split By Segment, 2019, $ Billion
5.1.1. Psoriasis
5.1.2. Other Drugs
5.1.3. Acne
5.2. Global Dermatology Drugs Market, Historic and Forecast, Split By Segment, 2015-2023
6. Dermatology Drugs Market Geography Regional Comparison
6.1. Global Dermatology Drugs Market, Split By Region, 2019, $ Billion
6.2. Global Dermatology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2015-2023
7. Appendix
7.1. Market Data Sources
7.2. NAICS Definitions Of Industry Covered In This Report
7.3. Research Methodology
7.4. Abbreviations
7.5. Currencies
7.6. Research Inquiries
7.7. The Business Research Company
8. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings